134 related articles for article (PubMed ID: 3015199)
1. Human von Willebrand factor: a multivalent protein composed of identical subunits.
Chopek MW; Girma JP; Fujikawa K; Davie EW; Titani K
Biochemistry; 1986 Jun; 25(11):3146-55. PubMed ID: 3015199
[TBL] [Abstract][Full Text] [Related]
2. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain.
Girma JP; Chopek MW; Titani K; Davie EW
Biochemistry; 1986 Jun; 25(11):3156-63. PubMed ID: 3015200
[TBL] [Abstract][Full Text] [Related]
3. Disulfide bonds required to assemble functional von Willebrand factor multimers.
Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
Cooney KA; Lyons SE; Ginsburg D
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
Bockenstedt P; Greenberg JM; Handin RI
J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
[TBL] [Abstract][Full Text] [Related]
7. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic studies on the structure of bovine von Willebrand factor.
Mascelli MA; Kirby EP
Biochemistry; 1988 Feb; 27(4):1274-84. PubMed ID: 2452652
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of human platelet von Willebrand factor.
Williams SB; McKeown LP; Krutzsch H; Hansmann K; Gralnick HR
Br J Haematol; 1994 Nov; 88(3):582-91. PubMed ID: 7819071
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
11. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
Dent JA; Galbusera M; Ruggeri ZM
J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
[TBL] [Abstract][Full Text] [Related]
15. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
[TBL] [Abstract][Full Text] [Related]
16. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
17. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
Carew JA; Quinn SM; Stoddart JH; Lynch DC
J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
[TBL] [Abstract][Full Text] [Related]
18. [Domain structure of human von Willebrand factor, and its modulators involved in the platelet adhesion process in vitro].
Fujimura Y; Fukui H; Usami Y; Titani K
Rinsho Ketsueki; 1991 May; 32(5):475-80. PubMed ID: 1870263
[TBL] [Abstract][Full Text] [Related]
19. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
Hamilton KK; Fretto LJ; Grierson DS; McKee PA
J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
[TBL] [Abstract][Full Text] [Related]
20. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.
Wise RJ; Dorner AJ; Krane M; Pittman DD; Kaufman RJ
J Biol Chem; 1991 Nov; 266(32):21948-55. PubMed ID: 1939217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
